SCHEMBL8335195

SCHEMBL8335195

O=CCCc1cc(Br)cc(Br)c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.48
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
GABRA1 P14867 1/20 0.42
GABRB1 P18505 1/20 0.42
GABRA2 P47869 1/20 0.42
GABRB2 P47870 1/20 0.42
TTR P02766 1/20 0.42
GFER P55789 1/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
MAPT P10636 3/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
PLEC Q15149 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23887401 0.82 MEN1 (0.36) ERN1CYP3A4TSHRTDP1CA12
SCHEMBL23887068 0.82 ERN1 (0.37) ERN1CYP3A4TSHRTDP1CA1
SCHEMBL3658549 0.81 ERN1 (0.52) ERN1CYP3A4TSHRTDP1CA12
SCHEMBL23887333 0.78 CYP2C9 (0.39) ERN1CYP3A4TSHRTDP1MEN1
SCHEMBL4136744 0.76 CYP3A4 (0.54) ERN1CYP3A4TSHRTDP1CA12
SCHEMBL27919070 0.76 CYP3A4 (0.54) ERN1CYP3A4TSHRTDP1CA12
SCHEMBL26620876 0.74 ERN1 (0.48) ERN1CYP3A4TSHRCA12CA1
SCHEMBL11613709 0.74 CYP3A4 (0.56) ERN1CYP3A4TSHRTDP1CA12
SCHEMBL67463 0.73 CYP3A4 (0.62) ERN1CYP3A4TSHRTDP1CA12
SCHEMBL28861293 0.73 HSP90AA1 (0.39) ERN1TDP1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004060376-A1 THE R-ISOMER OF BETA AMINO ACID COMPOUNDS AS INTEGRIN RECEPTOR ANTAGONISTS DERIVATIVES PHARMACIA CORPRATION (US) 2004-07-22 WO disclosed